In xenograft and glioblastoma organoid models, D34-919 blocks the ALDH1A3-PKM2 interaction, inhibiting XRCC1 lactylation and overcoming temozolomide and radiotherapeutic resistance in GSCs (Li G. et al., 2024). This evidence concerns the gene XRCC1 and glioblastoma.